The vascular endothelium forms the inner lining of blood vessels and serves as a dynamic interface between the bloodstream and the vessel wall. Far from being an inert barrier, endothelial cells continuously sense and respond to mechanical forces generated by blood flow. Among these forces, shear flow—the frictional drag exerted by flowing blood on the endothelial surface—stands out as a primary regulator of endothelial cell function. The influence of shear stress on gene expression patterns determines whether the endothelium maintains a quiescent, protective state or transitions toward a dysfunctional, pro-inflammatory phenotype. Understanding this relationship is central to vascular biology and the pathogenesis of diseases such as atherosclerosis.

Fundamentals of Shear Flow in the Vasculature

Shear flow, quantified as wall shear stress (WSS), represents the tangential force per unit area acting on the endothelial layer. WSS is determined by hemodynamic parameters including blood velocity, blood viscosity, and the geometry of the vessel lumen. In straight, unbranched segments of the arterial tree, flow is typically laminar and characterized by a unidirectional, high-magnitude WSS ranging from 10 to 70 dyn/cm². This stable, laminar flow pattern promotes endothelial quiescence and is strongly associated with vascular health.

At branch points, bifurcations, and curvatures, the flow profile changes dramatically. Flow separation, recirculation, and secondary flows generate a complex hemodynamic environment characterized by low-magnitude and oscillatory WSS. This disturbed flow pattern is inherently atheropromic, meaning it predisposes the vessel wall to inflammation and plaque formation. The carotid sinus, the outer wall of the internal carotid bifurcation, and the coronary arteries are classic sites where disturbed flow promotes the development of atherosclerotic lesions. These spatial variations in WSS directly correlate with the focal distribution of vascular disease, highlighting the clinical relevance of understanding how endothelial cells interpret mechanical cues.

Endothelial Mechanosensing: Translating Force into Signal

Endothelial cells possess an elaborate repertoire of mechanosensors that detect and transduce shear stress into biochemical signals. These sensors act at the cell surface, within the cytoplasm, and even at the nucleus, allowing the cell to rapidly integrate mechanical information and mount an appropriate transcriptional response.

The Glycocalyx as a Primary Sensor

The glycocalyx, a carbohydrate-rich layer coating the luminal surface of endothelial cells, serves as the frontline sensor of shear flow. Composed of proteoglycans, glycoproteins, and glycosaminoglycans such as heparan sulfate, the glycocalyx undergoes deformation in response to WSS. This deformation transmits mechanical strain to the underlying cortical cytoskeleton and activates associated signaling molecules. The integrity of the glycocalyx is essential for normal mechanotransduction; its degradation, which occurs in conditions like hyperglycemia and inflammation, impairs flow sensing and contributes to endothelial dysfunction.

Primary Cilia

Primary cilia are solitary, non-motile organelles that project from the apical surface of endothelial cells. These organelles function as specialized flow sensors, particularly in regions of low or disturbed flow. Primary cilia bend in response to shear stress, activating calcium influx through polycystin-2 channels. This calcium signal triggers downstream signaling cascades that influence gene expression. Notably, primary cilia are most abundant on endothelial cells at atheroprone sites, suggesting a protective role in sensing disruptive flow patterns.

Protein Complexes and Ion Channels

Endothelial cells use several plasma membrane-associated structures to detect shear stress. The mechanosensory complex composed of platelet endothelial cell adhesion molecule-1 (PECAM-1), vascular endothelial cadherin (VE-cadherin), and vascular endothelial growth factor receptor 2 (VEGFR2) acts as a critical force-sensing module. PECAM-1 directly transmits mechanical force, while VE-cadherin acts as an adaptor and VEGFR2 activates downstream phosphatidylinositol-3-kinase (PI3K) signaling. Ion channels, particularly Piezo1 and TRPV4, directly sense membrane tension and shear-induced deformation, mediating rapid calcium influx that triggers nitric oxide production and activation of transcription factors. These sensors do not operate in isolation; they form an integrated signaling network that ensures a coordinated cellular response to the mechanical environment.

Transcriptional Reprogramming in Response to Shear Flow

The coordinated activation of mechanosensors ultimately leads to profound changes in endothelial gene expression. The specific pattern of genes induced or repressed depends critically on the nature of the shear stress stimulus—laminar versus disturbed flow—and determines the functional state of the endothelium.

The Atheroprotective Gene Expression Program

Laminar shear stress activates a transcriptional program that promotes vasodilation, inhibits inflammation, and suppresses thrombosis. The transcription factor Kruppel-like factor 2 (KLF2) is a master regulator of this quiescent phenotype. KLF2 is potently induced by laminar shear stress through a signaling cascade involving MEK5, ERK5, and MEF2 transcription factors. KLF2 upregulates endothelial nitric oxide synthase (eNOS), the enzyme responsible for producing nitric oxide, a potent vasodilator and inhibitor of platelet aggregation and leukocyte adhesion. KLF2 also induces thrombomodulin, an anticoagulant protein, and suppresses the expression of adhesion molecules such as vascular cell adhesion molecule-1 (VCAM-1) and E-selectin. The transcription factor nuclear factor erythroid 2-related factor 2 (Nrf2) is also activated by laminar flow, inducing antioxidant genes like heme oxygenase-1 (HO-1) that protect endothelial cells from oxidative injury. Together, these changes establish an anti-inflammatory, anti-coagulant, and anti-proliferative milieu within the vessel wall.

The Atheropromic Gene Expression Program

Disturbed flow, in contrast, activates a program that drives endothelial dysfunction. This flow pattern strongly activates the transcription factor nuclear factor-kappa B (NF-κB). NF-κB induces a battery of pro-inflammatory genes encoding adhesion molecules (VCAM-1, ICAM-1, E-selectin) and chemokines (monocyte chemoattractant protein-1, MCP-1) that recruit circulating leukocytes into the vessel wall. Additionally, disturbed flow upregulates vasoconstrictors like endothelin-1 (ET-1) and suppresses eNOS expression, shifting the balance toward vasoconstriction. The bone morphogenetic protein-4 (BMP4) is also induced by disturbed flow and promotes oxidative stress and inflammation. The expression of platelet-derived growth factor (PDGF) is enhanced, contributing to smooth muscle cell proliferation and migration. This gene expression profile creates a pro-inflammatory, pro-oxidant, and pro-thrombotic environment that is permissive for the initiation and progression of atherosclerosis.

Mechanotransduction Pathways Linking Force to Gene Regulation

Understanding the signaling cascades that connect mechanosensors to the transcriptional machinery provides insight into how endothelial cells interpret flow and offers potential therapeutic targets.

The ERK5/KLF2 Signaling Axis

The MEK5/ERK5 signaling pathway is a key mediator of laminar shear-induced gene expression. ERK5 is a mitogen-activated protein kinase (MAPK) that phosphorylates and activates myocyte enhancer factor-2 (MEF2) transcription factors. MEF2 directly binds to the KLF2 promoter to drive its expression. This pathway is specifically activated by laminar flow and is essential to the atheroprotective phenotype. Impairment of ERK5 signaling in the endothelium leads to inflammation and accelerated atherosclerosis.

NF-κB and the Pro-Inflammatory Response

Disturbed flow promotes NF-κB activation through an integrin-dependent pathway involving the activation of IκB kinase (IKK). IKK phosphorylates IκBα, triggering its degradation and freeing NF-κB to translocate to the nucleus. The antioxidant effects of laminar flow, mediated by Nrf2, normally suppress NF-κB activity. The prevailing model suggests that it is the balance between Nrf2 and NF-κB activity that determines the net inflammatory state of the endothelium. Disturbed flow also activates the unfolded protein response (UPR) and enhances reactive oxygen species production, pathways that further amplify NF-κB signaling.

The Hippo/YAP/TAZ Pathway

Yes-associated protein (YAP) and transcriptional coactivator with PDZ-binding motif (TAZ) are mechanosensitive transcriptional regulators that have emerged as important mediators of shear stress effects. Laminar flow suppresses YAP/TAZ activity, promoting their cytoplasmic retention and degradation. In contrast, disturbed flow induces YAP/TAZ nuclear localization, where they coactivate pro-proliferative and pro-inflammatory genes. This pathway integrates mechanical cues from the cytoskeleton and cell-cell junctions to modulate endothelial gene expression.

Epigenetic Regulation

Shear flow influences gene expression at the chromatin level by altering histone modifications and DNA methylation. Laminar flow promotes histone acetylation at the promoters of protective genes like eNOS and KLF2, while repressive histone marks are deposited at pro-inflammatory gene loci. MicroRNAs also play a role. miR-10a, which is highly expressed in regions of laminar flow, suppresses NF-κB signaling by targeting IKK. Disturbed flow downregulates miR-10a, thereby disinhibiting the inflammatory pathway. These epigenetic mechanisms provide stable, long-term adaptations to the mechanical environment.

Clinical Implications and Therapeutic Horizons

The intimate link between shear flow and endothelial gene expression has profound implications for understanding and treating vascular disease. The focal nature of atherosclerosis, with plaques forming preferentially at sites of disturbed flow, directly reflects the local gene expression patterns established by hemodynamics. This principle informs strategies for diagnosis, risk stratification, and therapy.

Hemodynamic Modulation as a Therapeutic Strategy

One of the most effective ways to improve endothelial health is to enhance favorable shear stress profiles throughout the vasculature. Regular aerobic exercise increases cardiac output and blood flow velocity, augmenting WSS in large and medium-sized arteries. This increase in laminar shear stress acutely activates eNOS and chronically induces KLF2 expression, reinforcing the atheroprotective gene program. Exercise interventions have been shown to improve endothelial function, reduce arterial stiffness, and lower the risk of cardiovascular events in patients with established disease.

Pharmacological Targeting of Mechanotransduction

Several existing drugs appear to partially mimic the effects of laminar shear stress on the endothelium. Statins, beyond their cholesterol-lowering effects, directly induce KLF2 expression in endothelial cells, enhancing eNOS activity and suppressing inflammation. Part of the clinical efficacy of statins may derive from these "pleiotropic" effects on the endothelial transcriptional program. Antihypertensive agents, particularly ACE inhibitors and angiotensin receptor blockers, improve endothelial function in part by modulating shear-dependent signaling. Direct activators of the ERK5/MEF2 pathway or inhibitors of YAP/TAZ represent potential therapeutic strategies currently under investigation.

Biomarkers and Personalized Medicine

Given the central role of endothelial gene expression in vascular health, circulating markers of endothelial activation provide valuable prognostic information. Soluble forms of adhesion molecules (sVCAM-1, sICAM-1) are elevated in patients with atherosclerosis and predict future cardiovascular events. Assessing individual WSS patterns through computational fluid dynamics (CFD) modeling from imaging data (e.g., CT angiography or MRI) is emerging as a tool for personalized risk assessment. These techniques can identify regions of the vasculature experiencing atheroprone shear stress, allowing for early, targeted intervention before plaque development. As computational methods advance, integrating hemodynamic data with molecular biomarkers may yield powerful new strategies for predicting and preventing vascular disease.

Conclusion

Shear flow is a critical determinant of vascular endothelial cell gene expression, orchestrating functional programs that either protect against or promote arterial disease. The complex interplay between mechanosensors, signaling cascades, and transcriptional regulators governs the transition between endothelial quiescence and activation. Understanding these mechanisms provides a foundation for explaining the focal nature of atherosclerosis and for developing therapeutic strategies that leverage the forces of blood flow. Translating this knowledge into clinical practice—through lifestyle interventions, pharmacological agents that mimic protective flow, and personalized hemodynamic risk assessment—holds the potential to transform the prevention and treatment of cardiovascular disease.